## ULTA: Ulta Beauty, Inc. - XLY: Consumer Cyclical

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.4% in lower entry zone (3.0-6.0%), top 9% cross-sectional ranking. Short-term MRS_5 (2.5%) confirms momentum alignment. Strong momentum (+4.2% 5-day acceleration). Outperforming sector by 3.0%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($515.76)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. Ulta Beauty, Inc. Experiences Revision in Its Stock Evaluation Amid Strong Financial Metrics**
- Source: Markets Mojo | 20251201T103200 | Bullish | Relevance: 99%
- Ulta Beauty, Inc. has adjusted its valuation, showcasing strong financial metrics including a P/E ratio of 18, an enterprise value to EBITDA ratio of 11.39, and a high return on capital employed at 69.80%. These figures highlight the company's robust operational performance and profitability within the retail sector. Ulta's valuation metrics position it favorably compared to peers like Target Corp. and Williams-Sonoma, Inc., reflecting its competitive market standing.

**2. BLI Banque de Luxembourg Investments Lowers Position in Ulta Beauty Inc. $ULTA**
- Source: MarketBeat | 20251130T083638 | Neutral | Relevance: 99%
- BLI Banque de Luxembourg Investments reduced its stake in Ulta Beauty Inc. by 6.0% in the second quarter, selling 1,500 shares and holding 23,500 shares valued at $10.77 million. Despite this, other institutional investors like Price T Rowe Associates Inc. MD, T. Rowe Price Investment Management Inc., and JPMorgan Chase & Co. significantly increased their positions in the company. Ulta Beauty's stock currently holds a "Moderate Buy" consensus rating from analysts, with a consensus price target of $550.38, following strong earnings and revenue performance.

**3. Ulta Beauty Gears Up for Q3 Earnings: Here's What You Should Know**
- Source: TradingView | 20251201T170635 | Somewhat-Bullish | Relevance: 98%
- Ulta Beauty (ULTA) is poised to report its Q3 fiscal 2025 earnings on December 4th. The company is expected to benefit from sustained fragrance strength, improving makeup trends, and new brand introductions, alongside leveraging its omnichannel ecosystem. Despite potential increases in selling, general, and administrative expenses, the Zacks model predicts an earnings beat for ULTA, which currently holds a Zacks Rank of 2 and an Earnings ESP of +1.84%.

**4. 10 Best Performing Retail Stocks in 2025**
- Source: Insider Monkey | 20251130T232600 | Bullish | Relevance: 98%
- Ulta Beauty, Inc. (NASDAQ:ULTA) is highlighted as one of the best-performing retail stocks in 2025, with a year-to-date performance of 25.55% as of November 28 and held by 56 hedge funds. UBS reaffirmed a Buy rating with a $680 price target, citing strong Q3 results, consistent beauty demand, and a favorable competitive environment. The company also announced strategic expansion into the Middle East with its first branch in Kuwait.

**5. Neuberger Berman Group LLC Has $18.44 Million Stake in Ulta Beauty Inc. $ULTA**
- Source: MarketBeat | 20251130T122404 | Bullish | Relevance: 98%
- Neuberger Berman Group LLC significantly increased its stake in Ulta Beauty Inc. to $18.44 million, reflecting strong institutional confidence in the specialty retailer. Ulta Beauty also reported strong quarterly earnings, beating analyst estimates, which has led to raised price targets and a "Moderate Buy" consensus rating from analysts. The article highlights considerable institutional ownership and recent insider trading activity, alongside the company's solid financial performance and market valuation.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 13, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Oppenheimer | $675 | $615 | +10% |
| 2025-12-08 | Morgan Stanley | $640 | $600 | +7% |
| 2025-12-08 | TD Cowen | $725 | $600 | +21% |
| 2025-12-05 | DA Davidson | $650 | $625 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Oppenheimer | main | Outperform |
| 2025-12-08 | Morgan Stanley | main | Overweight |
| 2025-12-08 | TD Cowen | up | Buy |
| 2025-12-05 | DA Davidson | main | Buy |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+0.6%)
- Blackrock Inc.: 9.0% (-2.1%)
- JPMORGAN CHASE & CO: 5.5% (+99.0%)
- State Street Corpora: 4.4% (+2.3%)
- Sanders Capital, LLC: 2.8% (+8.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Analyst target momentum: 13 raises (avg +6%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_10 improving +4.2% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.42 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 48%, ROA 15%). Analyst sentiment positive (13 raises, avg +6%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $26.9B |
| Beta | 0.87 |
| 52W Range | $309.01 - $611.90 |
| Short Interest | 6.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.42 |
| Forward P/E | 19.5 |
| Current P/E | 21.5 |
| YoY Growth | 10.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -0.8% to 3.4% (+4.2% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 90th percentile. MRS_5 at 2.5% confirms short-term momentum alignment. Outperforming sector by 3.0pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (4.06), confirming momentum.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.42% (CS: 91) | Strong |
| RSI_14 | 62.8 | Neutral |
| MACD Histogram | 4.06 | Bullish |
| vs SMA20 | 1.053x | Above |
| vs SMA50 | 1.032x | Above |
| vs SMA200 | 1.188x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $547.64
- **Stop Loss:** $515.76 (5.8% risk)
- **Target:** $595.46 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 31
- **Position Value:** $16,976.84
- **Portfolio %:** 16.98%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-03-12 (Est: $7.15)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $4.60 | $5.14 | +11.7% |
| 2025Q3 | $5.04 | $5.78 | +14.6% |
| 2025Q2 | $5.80 | $6.70 | +15.5% |
| 2025Q1 | $7.15 | $8.46 | +18.4% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*